- Inhaled anticholinergics for COPD. Tanzi, Maria G. // Pharmacy Today;Dec2008, Vol. 14 Issue 12, p23
The article presents a study concerning the effectiveness of the inhaled anticholinergics for chronic obstructive pulmonary disease (COPD) treatment. Research shows that anticholinergics such as ipratropium and tiotropium were associated with increased risk for cardiovascular death in patients...
- Tiotropium for uncontrolled asthma. // Neurology Alert;Dec2010 Supplement, p1
The article focuses on a study which investigated the therapeutic use of tiotropium, a long-acting anticholinergic inhaler, for patients with chronic obstructive pulmonary disease (COPD).
- Tiotropium for Uncontrolled Asthma. // Internal Medicine Alert;12/15/2010 Clinical Briefs, p1
The article reports on the findings of a study that suggest that tiotropium, a long-acting anticholinergic inhaler, has been approved for the treatment of chronic obstructive pulmonary disease.
- New treatment for COPD launched. // Pulse;9/9/2002, Vol. 62 Issue 34, p4
Announces the launch of Spiriva, an anticholinergic bronchodilator for the treatment of chronic obstructive pulmonary disease by Boehringer Ingelheim and Pfizer in Great Britain.
- Long-Term Azithromycin for Prophylaxis of COPD Exacerbations. Kuritzky, Louis // Neurology Alert;Nov2011 Clinical Briefs, p22
The article offers brief information on a study by R. K. Albert which indicates potential favorable effects of azithromycin prophylaxis in patients with acute exacerbations of moderate-severe chronic obstructive pulmonary disease (AECOPD).
- Review Article. Lights and shadows of non-invasive mechanical ventilation for chronic obstructive pulmonary disease (COPD) exacerbations. Lopez-Campos, Jose Luis; Jara-Palomares, Luis; Muñoz, Xavier; Bustamante, Víctor; Barreiro, Esther // Annals of Thoracic Medicine;Apr-Jun2015, Vol. 10 Issue 2, p87
Despite the overwhelming evidence justifying the use of non-invasive ventilation (NIV) for providing ventilatory support in chronic obstructive pulmonary disease (COPD) exacerbations, recent studies demonstrated that its application in real-life settings remains suboptimal. European clinical...
- Safety of Inhaled Anticholinergics for COPD Scrutinized. Elliott, William T. // Critical Care Alert;Nov2008 Pharmacology Watch, p1
The article focuses on the safety of inhaled anticholinergics for the treatment of chronic obstructive pulmonary disease (COPD).
- Tiotropium cost effective in COPD in UK and Belgium. // PharmacoEconomics & Outcomes News;11/10/2012, Issue 666, p7
The article discusses research on adding tiotropium to standard care that references the study "Cost-utility analysis of tiotropium versus usual care in patients with chronic obstructive pulmonary disease (COPD) in the U.K. and Belgium," by R. Hettle et al in the October 2012 issue of...
- COMMENTARY. Niewoehner, Dennis E. // Evidence Based Medicine;May2003, p74
The author discusses aspects of drug effectiveness wherein he recommends that an anticholinergic agent can be combined with beta blocker agonist in the treatment pf patients with chronic obstructive pulmonary disease (COPD).